Click on headlines below to download research

A step forward on the Exosome delivery platform
ReNeuron Group | 15/09/2023

ReNeuron Group has generated in vivo data for CustomEX, marking a key step towards validating its proprietary stem cell-derived exosome platform. While…

Full steam ahead with CustomEx
ReNeuron Group | 30/05/2023

ReNeuron’s FY23 results provide a recap of financial and operational highlights from the period. Following the restructuring announcement in January…

Encouraging data for iPSCs opens potential
ReNeuron Group | 09/12/2022

ReNeuron Group has presented encouraging preclinical data surrounding the company’s conditionally immortalised induced pluripotent stem cell (CI…